(2R)-Oxiran-2-ylmethyl 4-methylbenzenesulfonate, 97.0%, 10g

3-Bromo-5-fluoropyridin-4-amine, 95.0%, 1g

2-Amino-4,5-diethoxybenzoic acid, 97.0%, 250mg

Methyl 5-chloro-6-methoxynicotinate, 95.0%, 5g

tert-butyl (4S)-4-amino-3,3-difluoropiperidine-1-carboxylate, 250mg

5-Methylmorpholine-2-carboxylic acid, 97%, 1g

4-Methyl-3-(trifluoromethyl)cinnamic acid, 5g

4-Chloro-6-fluoro-2-methylquinoline, 96.0%, 1g

2-(4-methoxy-6-methyl-2-pyrimidinyl)phenol, 95.0%, 1g

(Mercaptopropyl)methylsiloxane-dimethylsiloxane copolymers cSt 120-230, 100g

1,2,3,4,5,6-Hexahydrobenzo[b]azocine, 97%, 100mg

SPE polypropylene column CHROMABOND® Drug, 3 ml, 200 mg, 50 Piece(s)

p-Hexadecyloxybenzoic Acid, 95.0%, 1g